Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jun 30, 2011
June 30 (Bloomberg) -- John Lechleiter, chairman and chief executive officer of Eli Lilly & Co., talks about the company's revenue outlook as it faces the patent expiration of drugs including its biggest-selling medicine Zyprexa. Lechleiter speaks with Shannon Pettypiece on Bloomberg Television's "InsideTrack." (Source: Bloomberg)